asthma: A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors resulting in recurring periods of wheezing (a whistling sound while breathing), chest tightness, shortness of breath, mucus production and coughing. The symptoms appear due to a variety of triggers such as allergens, irritants, respiratory infections, weather changes, exercise, stress, reflux disease, medications, foods and emotional anxiety.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
225 |
4. Check minimum number of eventsNone |
225 |
5. Include endpointsNone |
225 |
6. Filter based on genotype QC (FinnGen only) |
196 |
Control definitions (FinnGen only)
- Control exclude
- IBD_BACT_INTEST_INFECTIONS
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- A04
- Name in latin
- Enteritis a Yersinia enterocolitica
Similar endpoints
↥List of similar endpoints to
Enteritis due to Yersinia enterocolitica
based on the number of shared cases.
Similar with more cases:
- Bacterial intestinal infections, IBD co-morbidities
- Infections, IBD-co-morbidities
- Intestinal infectious diseases
- Intestinal infectious diseases, including avohilmo, including avohilmo
- Certain infectious and parasitic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1504 | 800 | 693 |
| Only index persons | 1361 | 727 | 634 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 40.57 | 43.10 | 37.23 |
| Only index persons | 39.86 | 42.41 | 36.93 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 196 | 112 | 84 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 45.91 | 42.42 | 50.55 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 206
- Matched controls
- 2060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A04.6
ICD-10 Finland
Enteritis due to Yersinia enterocolitica
+∞
188.8
151
*
M03.2*A04.6
ICD-10 Finland
Postinfectious arthropathy in enteritis due to Yersinia enterocolitica
+∞
65.1
59
*
A07EC01
ATC
sulfasalazine; oral, rectal
9.3
37.5
52
72
J01MA02
ATC
ciprofloxacin; systemic
4.8
27.5
125
502
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
5.5
23.8
56
131
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
104.2
17.9
19
*
L01BA01
ATC
methotrexate; systemic
16.3
16.3
26
18
M13.9
ICD-10 Finland
Arthritis, unspecified
5.1
15.4
36
82
UJF32
NOMESCO Finland
Coloscopy
3.4
14.8
72
280
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.4
14.8
71
274
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
36.8
13.7
17
5
P01BA02
ATC
hydroxychloroquine; oral
4.6
13.3
35
88
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
6.2
12.2
22
39
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.8
11.6
86
417
M03.2
ICD-10 Finland
Other postinfectious arthropathies in diseases classified elsewhere
+∞
11.6
11
*
H02AB06
ATC
prednisolone; systemic
2.7
11.4
120
694
L04AX03
ATC
methotrexate; systemic
3.9
11.3
37
109
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
11.0
41
132
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.5
10.8
28
69
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
8.5
10.7
23
30
M02.1
ICD-10 Finland
Postdysenteric arthropathy
+∞
10.5
10
*
0084D
ICD-9 Finland
Intestinal infections due to other organisms, Other specified bacteria[ENTERITIS YERSINIA PSEUDOTUBERCULOSA]
+∞
10.5
10
*
A02BC02
ATC
pantoprazole; systemic
2.9
10.4
154
1037
A07EC02
ATC
mesalazine; oral, rectal
5.0
10.1
23
51
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.4
9.8
26
65
H02AB07
ATC
prednisone; oral
3.4
9.5
39
133
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
9.5
69
325
R50.9
ICD-10 Finland
Fever, unspecified
3.1
9.5
47
180
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
31.7
9.5
12
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.5
9.5
97
539
A07EA06
ATC
budesonide; oral, local oral
5.4
9.3
19
38
K59.1
ICD-10 Finland
Functional diarrhoea
4.5
9.3
24
59
ZX120
NOMESCO Finland
Intravenous
3.6
8.9
32
100
L88
ICPC
Rheumatoid/seropositive arthritis
5.1
8.8
19
40
L04AX01
ATC
azathioprine; systemic
7.0
8.7
21
33
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.0
8.5
25
68
UJF30
NOMESCO Finland
Ileoscopy through colon
3.4
8.2
32
106
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
7.9
30
97
P01AB01
ATC
metronidazole; oral, rectal
2.3
7.7
96
570
A07AA09
ATC
vancomycin; oral
83.0
7.5
8
*
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
6.5
7.3
18
30
J01MA12
ATC
levofloxacin; systemic
2.7
7.3
44
187
A02BC05
ATC
esomeprazole; systemic
2.2
6.9
90
538
C03CA01
ATC
furosemide; systemic
2.4
6.9
63
325
M45
ICD-10 Finland
Ankylosing spondylitis
7.3
6.6
15
22
K51.5
ICD-10 Finland
Left sided colitis
6.6
6.6
16
26
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.5
6.5
23
71
M01AX17
ATC
nimesulide; oral
2.4
6.4
52
253
K92.1
ICD-10 Finland
Melaena
4.2
6.3
17
43
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.1
6.0
91
569
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
39
52
9.02
28.64
1.7
1.4
—
—
—
0
0
56
118
6.14
26.89
2.8
1.4
—
—
—
0
0
31
53
6.71
18.03
1.4
1.2
—
—
—
0
0
26
57
5.08
11.54
1.3
1.4
0.28
0.08
iu/ml
—
5
9
81
422
2.52
9.01
3.1
2.0
2.64
2.95
mg/l
0.64
73
369
144
1010
2.41
7.77
17.8
10.5
4.21
4.08
e9/l
0.24
134
891
125
833
2.27
7.50
3.9
3.1
119.07
98.82
ug/l
0.34
120
791
135
937
2.28
7.23
5.3
3.7
0.00
0.00
estimate
-0.00
26
186
23
70
3.57
6.64
1.7
1.6
—
—
—
0
0
134
947
2.19
6.59
5.7
3.8
0.00
8.68
estimate
0.50
26
187
79
460
2.16
6.38
1.9
1.6
19.82
21.67
nmol/l
0.56
69
399
134
960
2.13
6.19
5.8
3.8
0.00
0.00
estimate
-0.00
24
172
24
80
3.26
6.03
1.6
2.0
10.69
4.01
iu/ml
—
8
19
76
456
2.06
5.54
1.4
1.3
1.95
1.17
u/ml
0.27
26
121
93
603
1.99
5.44
4.6
3.0
—
—
—
0
0
48
243
2.27
5.37
3.2
2.3
2.32
2.37
g/l
0.21
43
223
14
26
5.70
5.33
1.6
1.6
—
—
—
0
0
19
59
3.45
5.32
1.4
1.2
—
—
—
0
0
19
59
3.45
5.32
1.4
1.2
—
—
—
0
0
14
27
5.48
5.18
1.6
1.6
—
—
—
0
0
14
27
5.48
5.18
1.6
1.6
—
—
—
0
0
115
820
1.91
4.92
10.6
6.8
1.22
1.21
mmol/l
0.77
110
710
33
154
2.36
4.41
3.8
2.4
33.29
30.67
u/l
0.24
28
129
8
9
9.19
4.32
1.4
1.7
—
—
—
0
0
8
9
9.19
4.32
1.4
1.7
—
—
—
0
0
16
51
3.32
4.31
2.1
2.5
—
—
—
0
0
14
41
3.59
4.26
1.9
1.5
—
—
—
0
0
12
25
5.03
4.26
1.3
1.6
—
—
—
0
0
12
25
5.03
4.26
1.3
1.6
—
—
—
0
0
23
92
2.69
4.22
8.4
3.6
24.64
24.43
mmol/l
0.18
23
92
102
724
1.81
4.22
5.5
3.6
0.00
0.02
estimate
0.68
22
162
47
260
2.05
4.14
2.9
1.9
—
—
—
0
0
20
75
2.85
4.13
1.4
1.3
—
—
—
0
0
12
26
4.83
4.13
1.3
1.6
—
—
—
0
0
22
90
2.62
3.87
6.8
2.6
2.02
1.48
mmol/l
0.29
15
65
50
292
1.94
3.77
4.2
2.7
0.87
0.88
e6/l
0.02
34
146
13
34
4.01
3.76
1.5
1.6
—
—
—
0
0
47
270
1.96
3.71
4.9
2.8
4.83
3.38
e6/l
0.25
31
125
53
319
1.89
3.64
1.3
1.4
6.80
10.88
u/ml
0.33
23
122
23
100
2.46
3.58
1.0
1.0
—
—
—
0
0
86
603
1.73
3.55
4.1
3.8
33.89
37.18
ng/l
0.10
56
403
192
1715
2.76
3.55
29.3
13.8
25.66
22.08
mg/l
0.82
166
1397
66
429
1.79
3.54
6.6
3.7
1.02
1.02
kg/l
0.33
48
273
128
1003
1.73
3.51
5.6
4.8
6.38
6.66
mmol/l
0.84
122
934
80
556
1.72
3.37
2.8
3.1
2.38
2.35
mmol/l
1.84
75
511
13
43
3.16
3.31
4.6
2.0
24.04
23.99
mmol/l
0.01
13
43
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
7
8.78
3.28
1.3
1.3
—
—
—
0
0
14
49
2.99
3.26
1.8
1.4
167.50
306.27
ug/g
—
8
30
71
482
1.72
3.24
4.3
2.9
0.12
0.32
e6/l
1.94
56
344
51
317
1.81
3.14
5.0
3.4
67.61
272.94
ng/l
1.01
37
221
6
8
7.68
3.07
1.0
1.1
—
—
—
0
0
15
57
2.76
3.04
3.2
2.4
—
—
—
0
0
183
1628
2.11
2.95
23.9
13.2
85.57
85.91
ml/min/173m2
0.07
170
1498
23
110
2.23
2.92
1.6
1.3
—
—
—
0
0
95
716
1.61
2.81
2.6
2.0
91.95
98.04
pmol/l
0.67
56
355
71
506
1.62
2.61
5.2
3.7
0.00
0.01
estimate
0.50
25
172
6
11
5.58
2.56
2.3
4.4
—
—
—
0
0
11
37
3.08
2.53
1.3
1.2
177.50
264.40
u/ml
—
6
15
9
26
3.57
2.51
2.1
1.6
—
—
—
0
0
38
232
1.78
2.46
1.7
1.7
972.36
1262.03
nmol/l
1.50
32
186
11
38
3.00
2.45
8.5
2.3
8.29
8.37
kpa
0.07
11
38
33
193
1.85
2.45
3.1
1.7
—
—
—
0
0
60
417
1.62
2.42
2.5
2.1
—
—
—
0
0
13
52
2.60
2.41
1.8
1.5
—
—
—
0
0
5
8
6.37
2.38
1.4
1.6
—
—
—
0
0
5
8
6.37
2.38
1.4
1.6
—
—
—
0
0
15
65
2.41
2.38
1.2
1.3
—
—
—
0
0
13
53
2.55
2.32
3.3
2.2
—
—
—
0
0
11
40
2.85
2.31
1.3
1.3
—
—
—
0
0
8
23
3.58
2.29
1.4
1.2
—
—
—
0
0
6
13
4.72
2.29
1.2
1.2
—
—
—
0
0
32
190
1.81
2.27
3.3
1.7
—
—
—
0
0
73
539
1.55
2.26
5.3
3.1
0.00
0.00
estimate
-0.00
20
152
44
288
1.67
2.23
2.8
2.6
2.46
2.45
mmol/l
0.28
38
260
60
425
1.58
2.22
4.1
3.5
573.44
1211.39
ng/l
2.38
52
359
21
109
2.03
2.20
2.5
2.5
3.42
8.44
ug/l
2.17
16
100
10
36
2.87
2.17
1.3
1.3
—
—
—
0
0
10
36
2.87
2.17
1.4
1.6
—
—
—
0
0
6
14
4.38
2.16
1.2
1.1
—
—
—
0
0
10
37
2.79
2.10
1.7
1.9
—
—
—
0
0
9
31
2.99
2.10
2.2
1.6
—
—
—
0
0
7
21
3.41
1.98
1.0
1.3
—
—
—
0
0
5
11
4.63
1.95
2.4
4.1
17.60
12.91
%
—
5
11
8
28
2.93
1.88
1.1
1.4
—
—
—
0
0
8
28
2.93
1.88
1.1
1.4
—
—
—
0
0
5
12
4.24
1.83
1.0
1.1
464.80
245.92
mg/l
—
5
12
8
29
2.83
1.81
1.1
1.2
—
—
—
0
0
12
54
2.30
1.77
1.8
1.6
—
—
—
0
0
7
24
2.98
1.74
1.1
1.1
—
—
—
0
0
7
24
2.98
1.74
2.0
1.3
—
—
—
0
0
5
13
3.91
1.72
1.2
1.2
—
—
—
0
0
49
351
1.52
1.70
1.4
1.4
47.71
32.99
iu/ml
0.32
16
103
8
31
2.64
1.67
1.1
1.7
—
—
—
0
0
6
19
3.22
1.67
1.3
1.5
—
—
—
0
0
101
836
1.41
1.64
3.5
2.6
—
—
estimate
—
0
0
5
14
3.63
1.62
2.4
1.5
—
—
—
0
0
27
169
1.69
1.62
2.9
2.2
401.85
403.33
nmol/l
0.01
27
156
16
85
1.96
1.60
2.4
1.6
—
—
—
0
0
26
162
1.69
1.59
2.2
2.0
—
—
—
0
0
29
188
1.63
1.53
2.3
2.2
—
—
—
0
0
7
27
2.65
1.53
1.1
1.7
—
—
—
0
0
5
16
3.18
1.44
1.0
1.2
—
—
—
0
0
5
16
3.18
1.44
1.0
1.2
—
—
—
0
0
164
1501
1.45
1.35
32.6
17.4
13.72
13.53
%
1.20
164
1486
43
316
1.46
1.32
2.0
2.4
—
—
—
0
0
6
24
2.54
1.31
6.5
3.8
—
—
—
0
0
8
34
2.41
1.30
1.4
1.3
—
—
—
0
0
17
101
1.74
1.24
6.1
6.8
24.23
24.39
mmol/l
0.06
17
94
16
94
1.76
1.21
1.2
1.5
22.69
20.47
iu/l
0.08
11
78
40
299
1.42
1.12
1.8
2.2
—
—
—
0
0
63
509
1.34
1.11
4.3
3.9
22.52
13.63
mg/mmol
0.38
45
313
136
1227
1.32
1.08
4.0
3.4
—
—
—
0
0
5
22
2.30
1.04
1.4
1.3
—
—
—
0
0
17
108
1.63
1.00
7.8
7.7
25.15
25.11
mmol/l
0.01
17
108
26
185
1.46
0.95
7.0
8.2
1.39
0.87
mmol/l
0.36
21
152
48
388
1.31
0.84
2.0
1.9
0.83
1.10
mg/l
0.76
42
304
0
24
0.00
0.79
0.0
1.8
—
7.59
—
0
24
5
25
2.02
0.73
4.0
1.5
3.48
6.54
u/ml
—
5
25
14
203
0.67
0.71
3.6
4.3
26.33
31.50
%
—
6
135
5
26
1.95
0.71
4.6
5.0
9.38
8.79
pmol/l
—
5
26
12
77
1.59
0.70
1.6
1.2
—
—
—
0
0
17
119
1.47
0.69
2.0
2.8
68.75
73.22
ml/min/173m2
0.36
12
49
17
119
1.47
0.69
1.4
1.2
28.47
531.78
u/ml
1.48
17
113
14
94
1.53
0.68
6.0
2.4
105.07
173.71
ng/l
0.78
14
82
25
189
1.37
0.68
7.3
8.0
11.05
12.40
kpa
1.51
25
181
25
189
1.37
0.68
7.3
8.0
5.11
5.14
kpa
0.03
25
180
45
373
1.26
0.66
4.4
4.3
22.04
22.95
%
0.15
17
160
10
63
1.62
0.63
1.3
1.7
—
—
—
0
0
20
148
1.39
0.62
1.1
1.2
63.80
191.28
u/ml
—
5
51
5
30
1.68
0.62
1.2
1.3
—
—
—
0
0
10
64
1.59
0.59
2.7
3.1
21.50
2694.86
u/ml
—
10
57
18
133
1.39
0.57
1.5
1.4
—
—
—
0
0
13
94
1.41
0.47
1.1
1.4
236.19
277.90
miu/ml
—
6
50
133
1255
1.17
0.46
4.6
3.1
60.55
44.87
u/l
0.72
125
1211
5
32
1.58
0.42
1.8
1.1
—
—
—
0
0
5
33
1.53
0.41
1.2
2.3
—
—
—
0
0
194
1900
1.36
0.41
40.0
21.7
132.35
136.68
g/l
3.91
194
1882
174
1686
1.21
0.40
5.1
4.8
4.70
4.66
mmol/l
0.24
167
1579
27
225
1.23
0.39
8.8
6.8
104.67
104.12
mmol/l
0.26
27
225
5
35
1.44
0.39
1.2
1.6
—
—
—
0
0
169
1635
1.19
0.38
5.1
4.6
5.70
5.86
mmol/l
0.94
157
1510
173
1679
1.19
0.36
5.0
4.7
1.46
1.45
mmol/l
0.13
165
1566
5
76
0.65
0.36
1.0
1.2
0.82
0.89
g/l
—
5
76
12
91
1.34
0.34
1.4
2.7
57.35
56.09
u/ml
0.01
12
91
6
46
1.31
0.33
1.5
1.2
—
—
—
0
0
175
1707
1.17
0.30
5.8
5.3
2.76
2.74
mmol/l
0.10
168
1591
12
94
1.29
0.28
9.6
8.4
17.14
16.10
%
0.51
12
88
78
730
1.11
0.27
1.9
1.9
1.30
1.39
mmol/l
0.65
69
629
5
75
0.66
0.26
1.6
1.6
—
—
—
0
0
5
75
0.66
0.26
1.0
1.2
1.46
1.52
g/l
—
5
75
166
1618
1.13
0.26
6.0
5.3
1.85
1.85
mu/l
0.02
158
1505
19
162
1.19
0.24
7.9
8.9
121.89
122.27
g/l
0.02
19
157
45
413
1.11
0.22
1.5
1.7
—
—
—
0
0
34
311
1.11
0.18
1.7
1.6
—
—
—
0
0
163
1598
1.10
0.17
4.3
4.0
1.29
1.29
mmol/l
0.02
155
1480
11
92
1.21
0.16
2.1
2.9
0.66
0.63
%
0.16
11
92
31
284
1.11
0.16
2.9
2.7
0.73
0.74
ug/l
0.01
17
159
11
125
0.87
0.10
5.9
3.6
1.24
1.23
mmol/l
0.57
11
113
10
87
1.16
0.09
1.5
1.9
—
—
—
0
0
5
62
0.80
0.08
1.0
1.3
—
—
—
0
0
18
168
1.08
0.06
7.7
7.9
—
—
—
0
0
16
156
1.03
0.00
3.0
3.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
8.94
—
0
9
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
6
64
0.94
-0.00
1.5
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
—
—
0
0
8
81
0.99
-0.00
1.8
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
42.20
—
0
5
9
92
0.98
-0.00
1.2
1.6
465.58
295.32
mu/l
—
9
85
Mortality – FinRegistry
↥Association
Association between endpoint YERSINIAENTERITIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| YERSINIAENTERITIS | 1.696 [1.28, 2.24] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.191 |
During the follow-up period (1.1.1998 — 31.12.2019), 105 out of 626 females with YERSINIAENTERITIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| YERSINIAENTERITIS | 1.525 [1.11, 2.1] | 0.01 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 71 out of 526 males with YERSINIAENTERITIS died.
Mortality risk
Mortality risk for people of age
years, who have YERSINIAENTERITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.154% | 0.26% |
| 5 | 1.027% | 1.703% |
| 10 | 2.513% | 4.274% |
| 15 | 4.725% | 8.398% |
| 20 | 8.16% | 14.254% |
Relationships between endpoints
↥Index endpoint: YERSINIAENTERITIS – Enteritis due to Yersinia enterocolitica
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data